Endovia Health Sciences, Inc. (EDVA)
NYSE American · Healthcare · Biotechnology
$0.1659+4.08%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $1.8M
- 52-week range
- $0.152 – $13.40
- 52-week change
- −98.29%
- EPS (trailing)
- −$22.83
Fiscal year to Dec 2025
- Revenue
- $73K (−90.88%)
- Net income
- −$25.2M
- Operating margin
- −19415.3%
- Diluted EPS
- −$11.97
From the company’s annual report on SEC EDGAR.
About Endovia Health Sciences, Inc.
Endovia Health Sciences, Inc. develops a diversified cannabinoid health sciences platform that translates science into regulated therapies and trusted health and wellness products for people and animals in Ireland, United Kingdom, Australia, and Latin America. Its product includes CannEpil a pharmaceutical-grade cannabinoid formulation comprising cannabidiol and tetrahydrocannabinol isolates in an oral liquid solution. Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. The company is based in Fort Lauderdale, Florida.
Headquarters: Fort Lauderdale, United States · 1 employees · EndoviaSciences.com